Celldex Therapeutics to Present at the Jefferies 2012 Global Healthcare ConferenceNEEDHAM, Mass.--(BUSINESS WIRE)--May. 31, 2012--
Celldex Therapeutics, Inc. (Nasdaq: CLDX) today announced that
Anthony S. Marucci, President and Chief Executive Officer of
Celldex Therapeutics, Inc., will present at the
Jefferies 2012 Global Healthcare Conference in
New York City on
Wednesday, June 6, 2012 at
8:30 a.m. ET. A live webcast of the Company's presentation will be available online on the "Presentations" page of the "Investors" section of the Celldex website at
http://www.celldextherapeutics.com and will be archived for 30 days following the event.
About Celldex Therapeutics, Inc.
Celldex Therapeutics is the first antibody-based combination immunotherapy company. Celldex has a pipeline of drug candidates in development for the treatment of cancer and other difficult-to-treat diseases based on its antibody focused Precision Targeted Immunotherapy (PTI) Platform. The PTI Platform is a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators used in optimal combinations to create novel disease-specific drug candidates. For more information, please visit http://www.celldextherapeutics.com.
Source: Celldex Therapeutics, Inc.
Celldex Therapeutics, Inc.
Anthony S. Marucci, 781-433-0771
President and CEO
or
Avery W. Catlin, 781-433-0771
Chief Financial Officer
IR@celldextherapeutics.com
or
For Media:
BMC Communications
Brad Miles, 646-513-3125
bmiles@bmccommunications.com
